Castleview Partners’s Synopsys SNPS Stock Holding History

Castleview Partners’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-490	Closed	-$230K	–	220
2025 Q4	$230K	Sell	490 -1	-0.2%	-$444	0.11%	175
2025 Q3	$242K	Buy	+491	New	+$278K	0.13%	150

Other funds holding SNPS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nvidia Corp Santa Clara, California $18.4B AUM 362.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Castleview Partners's SNPS Position: Q1 2026 in Review

Castleview Partners sold out of Synopsys (SNPS) in Q1 2026, closing a stake of 490 shares — an estimated $230K sold.

Castleview Partners first reported a position in SNPS in Q3 2025 and held it in 2 quarters. The position peaked at $242K in Q3 2025. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

Castleview Partners reported no remaining Synopsys position as of Q1 2026 after selling out during the quarter.
Castleview Partners sold 490 Synopsys shares in Q1 2026, an estimated $230K.
Castleview Partners first reported a position in Synopsys in Q3 2025 and held it in 2 quarters.
Castleview Partners's Synopsys position peaked at $242K in Q3 2025.
1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Castleview Partners's 13F filing for Q1 2026, filed 1 May 2026.